老年急性心肌梗死合并心源性休克患者的结局
基于RETROSHOCK登记研究,纳入1716例连续AMICS患者,其中496例(28.9%)≥75岁。老年患者直接入住三级中心、接受机械循环支持(如Impella®)和血运重建的比例均显著低于年轻患者。≥75岁患者30天死亡率为73.4%,存活者入院时左室射血分数更高、动脉乳酸更低。多因素分析显示,高龄、入院心率快和乳酸高与30天死亡风险增加独立相关。
要点
- ≥75岁AMICS患者30天死亡率为73.4%,提示该人群预后极差。
- 老年患者接受Impella®(8.9% vs 15.0%)和血运重建(76.8% vs 90.2%)的比例显著低于年轻患者。
- ≥75岁30天存活者入院时乳酸更低(3.2 vs 5.5 mmol/L)、LVEF更高(30.2% vs 26.5%)。
- 多因素分析中,年龄(HR 1.09)、心率(HR 1.01)和乳酸(HR 1.11)与30天死亡风险独立相关。
适用人群与场景
- 连续入院的急性心肌梗死合并心源性休克(AMICS)患者,来自RETROSHOCK登记研究,转诊至三级大学医院评估和治疗。
- 年龄≥75岁的老年AMICS患者为分析重点;原文未明确列出排除标准。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:基于RETROSHOCK登记研究的回顾性分析,连续纳入1716例AMICS患者,单中心三级大学医院。
- ≥75岁患者496例(28.9%),30天死亡率为73.4%。
- 老年患者直接入住三级中心比例较低(59.4% vs 69.9%,P=0.003),接受Impella®比例较低(8.9% vs 15.0%,P=0.003),血运重建尝试比例较低(76.8% vs 90.2%,P<0.001)。
- ≥75岁30天存活者入院时LVEF更高(30.2%±12.5% vs 26.5%±11.8%,P=0.004),动脉乳酸更低(3.2[2.2-5.2] mmol/L vs 5.5[3.3-8.2] mmol/L,P<0.001)。
- ≥75岁患者多因素分析:年龄(HR 1.09,95%CI 1.05-1.14,P<0.001)、心率(HR 1.01,95%CI 1.001-1.014,P=0.03)、乳酸(HR 1.11,95%CI 1.07-1.16,P<0.001)与30天死亡风险增加相关。
证据类型、等级与局限
- 证据类型:回顾性登记研究(RETROSHOCK registry),单中心,观察性设计。
- 局限:原文未明确提及证据等级;设计本身为回顾性、单中心,可能存在选择偏倚和未测量混杂。
对床旁实践的改变
- 对于≥75岁AMICS患者,入院时高乳酸和高心率提示30天死亡风险显著增加,应积极评估和治疗。
- 老年患者接受机械循环支持和血运重建的比例较低,但原文未提供这些干预与结局的因果证据,不能据此改变适应证。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Despite advances in treatment of patients with cardiogenic shock following acute myocardial infarction (AMICS) in-hospital mortality remains around 50%. Outcome varies among patient subsets and the elderly often have a poor a priori prognosis. We sought to investigate outcome among elderly AMICS patients referred to evaluation and treatment at a tertiary university hospital.
METHODS: Current analysis was based on the RETROSHOCK registry comprising consecutive AMICS patients admitted to tertiary care. Patients in the registry were individually identified and validated.
RESULTS: Of 1,716 admitted patients, 496 (28.9%) patients were ≥75 years old. Older patients were less likely to be admitted directly to a tertiary centre (59.4% vs. 69.9%, P = 0.003), receive mechanical support devices (i.e., Impella® (8.9% vs. 15.0%, P = 0.003), and undergo revascularization attempt (76.8% vs. 90.2%, P < 0.001). Thirty-day survivors ≥75 years were characterized by having higher left ventricular ejection fraction (30.2% ± 12.5% vs. 26.5% ± 11.8%, P = 0.004) and lower arterial lactate (3.2[2.2-5.2] mmol/L vs. 5.5[3.3-8.2] mmol/L, P < 0.001) at admission. In a multivariable analysis of patients ≥75 years, higher age (HR 1.09, 95% CI 1.05-1.14, P < 0.001), higher heart rate (HR 1.01, 95% CI 1.001-1.014, P = 0.03), and higher lactate (HR 1.11, 95% CI 1.07-1.16, P < 0.001) at admission were associated with an increased risk of 30-day mortality.
CONCLUSION: Among patients ≥75 years with AMICS referred for tertiary specialized treatment, 30-day mortality was 73.4%. Survivors were characterized by lower arterial lactate and heart rate at admission.
参考来源
- Ratcovich HL, Josiassen J, Helgestad OKL, et al. Outcome in Elderly Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction. Shock. 2022. PMID: 34265831. doi:10.1097/SHK.0000000000001837
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。